Doxycycline: In reply to J.-M. Bonnetblanc;Doxycycline: Réponse à Jean-Marie Bonnetblanc

Annales de Dermatologie et de Venereologie

Volumn 130, Issue 8-9 I, 2003, Pages 789-

  Tsankov, N ^a,b   Antonov, D ^a   Grozdev, I ^a  

^a Chaire de Dermatol et Venereologie   (Bulgaria)

^b NONE   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CYCLIC AMP; DOXYCYCLINE; TETRACYCLINE DERIVATIVE;

ARACHIDONIC ACID METABOLISM; DISEASE EXACERBATION; DRUG EFFECT; DRUG RESPONSE; GENETIC PREDISPOSITION; HUMAN; LETTER; PATHOPHYSIOLOGY; PHOTOTOXICITY; PSORIASIS; RISK FACTOR; SYMPTOM;

ANTI-BACTERIAL AGENTS; DOXYCYCLINE; HUMANS; PSORIASIS;

EID: 0142087850     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Bonnetblanc JM. Doxycycline. Ann Dermatol Venereol 2002;129:874-82.
2. Tsankov N, Botev-Zlatkov N, Lazarova A. Psoriasis and drugs : influence of tetracyclines on the course of psoriasis. J Am Acad Dermatol 1988;19:620-32.
3. Bergner T, Przybilla B. Psoriasis and tetracyclines. J Am Acad Dermatol 1990;23:770.
4. Tsankov N, Lazarova A. Psoriasis and tetracyclines. [reply.] J Am Acad Dermatol 1990;23:770-1.
5. Tsankov N, Kazandjieva J, Drenovska K. Drugs in exacerbation and provocation of psoriasis. Clin Dermatol 1998;16:333-51.
6. Tsankov N, Angelova I, Kazandjieva J. Drug-induced proriasis. Am J Clin Dermatol 2000;1:159-65.